Results 31 to 40 of about 35,158 (167)
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, Volume 20, Issue 5, Page 1161-1184, May 2026.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Bone metastases from osteosarcoma [PDF]
, 2003 Bony metastases in patients with osteosarcoma are unusual and normally appear late in the course of the disease. We report our experience with eight such patients, four with solitary and four with multiple metastases.
Diaz-de-Rada, P. (Pablo) +3 more
core
Métastases pleuro-pulmonaires des néoplasies extra-thoraciques
The Pan African Medical Journal, 2017 Les poumons reçoivent la totalité du drainage veineux du corps expliquant la grande fréquence des métastases pleuro-pulmonaires de plusieurs cancers.
Farid Badri +5 more
doaj +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
Molecular Oncology, Volume 20, Issue 5, Page 1364-1378, May 2026.This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?] [PDF]
, 2017 The treatment of urothelial bladder cancer has changed very little in recent years, with high rates of disease recurrence and progression, even in low aggressive urothelial bladder cancer. Immunotherapy has already proven its effectiveness as a treatment
Adam, S.M. +3 more
core
Métastase géante sous cutanée d'un carcinome vésiculaire de la thyroïde: à propos d'un cas
The Pan African Medical Journal, 2018 La localisation secondaire sous-cutanée de carcinome vésiculaire de la thyroïde est inhabituelle. Elle représente au plus 5,8% de sites métastatiques préférentielles de la thyroïde.
Ny Ony Tiana Andrianandrasana +3 more
doaj +1 more source
RIPK4 function interferes with melanoma cell adhesion and metastasis
Molecular Oncology, Volume 20, Issue 5, Page 1115-1139, May 2026.RIPK4 promotes melanoma growth and spread. RIPK4 levels increase as skin lesions progress to melanoma. CRISPR/Cas9‐mediated deletion of RIPK4 causes melanoma cells to form less compact spheroids, reduces their migratory and invasive abilities and limits tumour growth and dissemination in mouse models.
Norbert Wronski +9 more
wiley +1 more source
Métastase pancréatique d’un carcinome rénal à cellules claires : A propos d’un cas.
Avicenna Medical ResearchRésumé: Les métastases pancréatiques du carcinome rénal à cellules claires (CRCC) sont rares et surviennent souvent plusieurs années après la néphrectomie.
D Belabdi +5 more
doaj +1 more source
Une cause rare de plexopathie brachiale: une metastase d'un cancer du sein
The Pan African Medical Journal, 2014 Nous rapportons le cas d'une patiente de 50 ans ayant une histoire de cancer du sein et qui accuse une symptomatologie d'atteinte du plexus brachial. L'IRM montre une masse qui envahie le plexus brachial compatible avec une métastase.
Mustapha Maéroufi +4 more
doaj +1 more source
FEBS Open Bio, Volume 16, Issue 5, Page 979-999, May 2026.Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava +3 more
wiley +1 more source